Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 440Lung Neoplasms 170Neoplasms 31Adenocarcinoma of Lung 27Neoplasm Metastasis 23Breast Neoplasms 23Prostatic Neoplasms 19Squamous Cell Carcinoma of Head and Neck 17Small Cell Lung Carcinoma 17Colorectal Neoplasms 13Melanoma 12Stomach Neoplasms 11Adenocarcinoma, Bronchiolo-Alveolar 11Pancreatic Neoplasms 10Ovarian Neoplasms 10Carcinoma, Renal Cell 10Head and Neck Neoplasms 9Urinary Bladder Neoplasms 8Recurrence 8Esthesioneuroblastoma, Olfactory 8Carcinoma, Squamous Cell 8Salivary Gland Neoplasms 7Esophageal Neoplasms 7NSCLC 6Carcinoma 6Advanced Non-Small Cell Lung Cancer 6Sarcoma 5Pleural Effusion, Malignant 5Parkinson Disease 4, Autosomal Dominant Lewy Body 5Carcinoma, Transitional Cell 5

Interventions

sotorasib 1pembrolizumab 1lorlatinib 1liposomal doxorubicin 1encorafenib 1cemiplimab 1binimetinib 1berzosertib 1Topotecan 1Taxes 1Paclitaxel 1PX-866 1NVP-BKM120 1Lomustine 1Irinotecan 1Gemcitabine 1Everolimus 1Doxorubicin 1Docetaxel 1Cetuximab 1Carboplatin 1Albumin-Bound Paclitaxel 13-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hereditary Sensory and Autonomic Neuropathies × Docetaxel × Thoracic × Clear all
NCT01204099 2018-05-16

Study of PX-866 and Docetaxel in Solid Tumors

Seagen Inc.

Phase 1/2 Completed
223 enrolled
Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡